Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
ISCO (OTCBB: ISCO)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
SEC
International Stem Cell Corporation Announces Collaboration with Scripps Research Institute's Center for Regenerative Medicine to Study Parthenogenetic Stem Cells
Nov 19, 2009 07:30 AM |
ISCO
International Stem Cell Corporation Announces Strategic Enhancement of its Management Team
Nov 10, 2009 07:15 AM |
ISCO
International Stem Cell Corporation and Reproductive Medicine Associates of New York Announce Breakthrough in Creating an Abundant and Ethical New Source of Human Pluripotent Stem Cells
Oct 27, 2009 07:30 AM |
ISCO
International Stem Cell Corporation and Absorption Systems Announce Potential Stem Cell Alternative to Live Animal Testing for Corneal Damage
Oct 05, 2009 08:19 AM |
ISCO
Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
Sep 23, 2009 03:15 PM |
ISCO
American Diversified Holdings Corporation to Be Featured Presenter at the International Stem Cell Network's New York City Symposium
Sep 10, 2009 09:01 AM |
ISCO
American Diversified Holdings Corporation Retains The International Stem Cell Network to Advise on Strategic Opportunities Into the Stem Cell Industry
Aug 20, 2009 09:00 AM |
ISCO
International Stem Cell Corporation Adds Strength Through Expansion of its Management Structure
Jul 07, 2009 12:00 PM |
ISCO
International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a Therapeutic Medium for Cytograft's Living Vascular Grafts and GenVec Reports Fourth Quarter and 2008 Year-End Financial Results
Mar 13, 2009 09:30 AM |
BIIB
,
BNVI
,
GNVC
,
ISCO
International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a Therapeutic Medium for Cytograft's Living Vascular Grafts
Mar 13, 2009 09:00 AM |
ISCO
More..
More..
International Stem Cell Corporation Issues Letter to Shareholders
Aug 04, 2009 08:31 AM |
ISCO
International Stem Cell Corporation Adds Strength Through Expansion of its Management Structure
Jul 06, 2009 05:02 PM |
ISCO
International Stem Cell Corporation Secures $5 Million Financing Commitment
Jul 06, 2009 10:01 AM |
ISCO
International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells
May 27, 2009 08:45 AM |
ISCO
International Stem Cell Corporation Provides Comments on National Institutes of Health’s Proposed Stem Cell Research Guidelines
May 19, 2009 08:51 AM |
ISCO
International Stem Cell Corporation Announces the Release of DataTrends Equity Research Group Investor’s Corporate Profile® of the Company
May 14, 2009 11:09 AM |
ISCO
International Stem Cell Reports Excellent Preliminary Results for Skin Rejuvenation
Apr 21, 2009 08:44 AM |
ISCO
International Stem Cell Corporation Receives Third $1M Tranche under a $5 Million Financing
Mar 17, 2009 08:33 AM |
ISCO
International Stem Cell Corporation enters into an Agreement with Cytograft Tissue Engineering to Develop a Therapeutic Medium for Cytograft’s Living Vascular Grafts
Mar 12, 2009 08:20 AM |
ISCO
International Stem Cell Corporation Applauds President Obama’s Decision to Allow Funding of Parthenogenetic Stem Cell Research
Mar 10, 2009 08:37 AM |
ISCO
More..
Form 4 Janus Jeffrey For: Nov 05 (10K)
Nov 09, 2009 08:14 PM
Form 4 Aldrich Kenneth C For: Nov 05 (10K)
Nov 09, 2009 08:13 PM
Form 4 Lundstrom Brian For: Nov 05 (10K)
Nov 09, 2009 08:12 PM
Form 3 Lundstrom Brian For: Nov 05 (10K)
Nov 09, 2009 08:11 PM
Form 4 Semechkin Andrei For: Oct 09 (10K)
Oct 13, 2009 07:01 PM
Form 4 Semechkin Andrei For: Sep 30 (10K)
Oct 02, 2009 05:27 PM
Form 4 Semechkin Andrei For: Jun 30 (10K)
Jul 07, 2009 09:01 PM
Form 4 Semechkin Andrei For: Apr 29 (10K)
May 01, 2009 05:11 PM
Form 4 Semechkin Andrei For: Mar 16 (10K)
Mar 17, 2009 01:07 PM
Form 4 Semechkin Rouslan For: Dec 30 (10K)
Jan 02, 2009 02:40 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
ISCO
Compare to S&P
YTD
190.00 %
140.01 %
4 Weeks
-10.77 %
-11.73 %
12 Weeks
-34.09 %
-37.86 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-0.01 %
EPS Growth in Last Year:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
